연구성과로 돌아가기
2023 연구성과별 연구자 정보 (1525 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Chun, Sehwan | Chun, S | 2 | CORESTEMCHEMON Inc, Cent Res Ctr, Seoul, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Chun, Sehwan | Chun, S | 2 | Kyung Hee Univ, Dept Biol, Seoul, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Lee, Tae Yong | Lee, TY | 3 | CORESTEMCHEMON Inc, Cent Res Ctr, Seoul, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Lee, Tae Yong | Lee, TY | 3 | Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Seo, Yunjeong | Seo, Y | 4 | CORESTEMCHEMON Inc, Cent Res Ctr, Seoul, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Kim, Kwijoo | Kim, K | 5 | CORESTEMCHEMON Inc, Cent Res Ctr, Seoul, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Park, Jinseok | Park, J | 6 | Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Sung, Wonjae | Sung, W | 7 | Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Oh, Ki-Wook | Oh, KW | 8 | Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea | E-6996-2017 | Oh, Ki-wook | 0000-0001-6011-629X | Oh, Ki-wook | kimsh1@hanyang.ac.kr; | |
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Lee, Sanggon | Lee, S | 9 | Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Lee, Sanggon | Lee, S | 9 | Chung Ang Univ, Dept Neurol, Gwangmyeong Hosp, Gwangmyeong, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Park, Jin-Sung | Park, JS | 10 | Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Neurol, Daegu, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Oh, Juyeon | Oh, J | 11 | Dankook Univ, Coll Nursing, Cheonan, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | Chung, Kyung Cheon | Chung, KC | 12 | Bethesda Gospel Hosp, Dept Neurol, Yangsan, South Korea | kimsh1@hanyang.ac.kr; | |||||
| Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study | An, Hyonggin | An, H | 13 | Korea Univ, Dept Biostat, Coll Med, Seoul, South Korea | kimsh1@hanyang.ac.kr; |
페이지 이동: